Encounter for screening for malignant neoplasm of cervix Z12. 4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z12.
Test Details If HPV DNA, High Risk is Detected, then HPV Genotypes 16 and 18 will be performed at an additional charge (CPT code(s): 87625).
ICD-10 code Z12. 4 for Encounter for screening for malignant neoplasm of cervix is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
619: Unspecified abnormal cytological findings in specimens from cervix uteri.
196305: Gynecologic Pap Test (Image-guided), Liquid-based Preparation and High-risk HPV (Cobas®) With Reflex to HPV Genotypes 16 and 18 | Labcorp.
1 screening HPV services are to be billed with Healthcare Common Procedure Coding System (HCPCS) code G0476. These services require dual diagnosis codes. The primary International Statistical Classification of Diseases and Related Health Problems, 10th revision, (ICD-10) code Z11.
R87. 810 - Cervical high risk human papillomavirus (HPV) DNA test positive | ICD-10-CM.
411, Encounter for gynecological examination (general) (routine) with abnormal findings, or Z01. 419, Encounter for gynecological examination (general) (routine) without abnormal findings, may be used as the ICD-10-CM diagnosis code for the annual exam performed by an obstetrician–gynecologist.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
R87. 610, Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)
CPT 57461 describes a colposcopy of the cervix, including the vagina. And it includes loop electrode conization of the cervix.
CPT codes for cervical biopsy are 57454* (Colposcopy [vaginoscopy]; with biopsy[s] of the cervix and/or endocervical curettage) and 57500* (Biopsy single or multiple or local excision of lesion with or without fulguration [separate procedure]).
It is usually sufficient to test one specimen. Therefore, no more than one (1) unit of 87624 or 87625 for human papillomavirus molecular testing may be billed for the same date of service. More than one type of molecular test for the same organism will not be reimbursed for the same date of service.
HCPCS code G0476 for Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test as maintained by CMS falls under Other Services .
CPT code 90650 is an FDA-approved HPV vaccine for females only age 9-26. For recipients age 9-18, code 90650 is reimbursed through the VFC program. The three-dose schedule for either code for recipients over age 18 must begin and end before the recipient turns 27.
Testing for Chlamydia (CPT Code 87491) Routine screening for chlamydia infection should be performed annually in all sexually active female patients who are 25 years of age or younger (and is recommended more often for patients who have high risk factors).